The data support SCN1A-dsAS as an interesting target for development of precision medicine therapeutic approaches for SCN1A related DS aiming to enhance expression of functional Nav1.1 and to overcome haploinsufficiency. The gene discussed is SCN1A; the disease is Dravet syndrome.